IBIO Form DEFA14A: Additional definitive proxy soliciting materials

IBIO, INC. Form DEFA14A: Additional definitive proxy soliciting materials

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

2022-12-02: Form DEFA14A; Description DEFA14A; Document ibio-20221201xdefa14a.htm.
2022-05-26: Form DEFA14A; Description DEFA14A; Document tmb-20220526xdefa14a.htm.
2022-05-13: Form DEFA14A; Description DEFA14A; Document ibio-20220512xdefa14a.htm.
2022-05-13: Form DEFA14A; Description DEFA14A; Document ibio-20220513xdefa14a.htm.

Filed	Form	Description	Document
2022-12-02	DEFA14A	DEFA14A	ibio-20221201xdefa14a.htm
2022-05-26	DEFA14A	DEFA14A	tmb-20220526xdefa14a.htm
2022-05-13	DEFA14A	DEFA14A	ibio-20220512xdefa14a.htm
2022-05-13	DEFA14A	DEFA14A	ibio-20220513xdefa14a.htm
2021-12-22	DEFA14A	DEFA14A	tm2136114d2_defa14a.htm
2021-12-21	DEFA14A	DEFA14A	tm2136006d1_defa14a.htm
2021-12-10	DEFA14A	DEFA14A	tmb-20211210xdefa14a.htm
2021-12-03	DEFA14A	DEFA14A	tmb-20211203xdefa14a.htm
2021-11-30	DEFA14A	DEFA14A	tmb-20211130xdefa14a.htm
2021-11-30	DEFA14A	DEFA14A	tmb-20211130xdefa14a.htm
2021-11-30	DEFA14A	DEFA14A	tmb-20211130xdefa14a.htm
2021-11-24	DEFA14A	DEFA14A	tmb-20211124xdefa14a.htm
2021-11-17	DEFA14A	DEFA14A	tmb-20211117xdefa14a.htm
2021-11-16	DEFA14A	DEFA14A	tmb-20211116xdefa14a.htm
2021-11-09	DEFA14A	DEFA14A	tm2132459d2_defa14a.htm
2021-11-09	DEFA14A	DEFA14A	tm2132459d1_defa14a.htm
2021-10-26	DEFA14A	DEFA14A	tm2129710d4_defa14a.htm
2021-10-26	DEFA14A	DEFA14A	tm2129710d3_defa14a.htm
2020-11-06	DEFA14A	DEFA14A	tm2035310d1_defa14a.htm
2020-03-02	DEFA14A	DEFA14A	tm2011331d1_defa14a.htm
2020-02-06	DEFA14A	DEFA14A	tm201696d2_defa14a.htm
2020-01-09	DEFA14A	FORM 8-K	tm201707-1_8k.htm
2017-12-07	DEFA14A	DEFA14A	tv481003_defa14a.htm
2016-03-02	DEFA14A	FORM 8-K	v433263_8k.htm
2016-01-29	DEFA14A	FORM 8-K	v430116_8k.htm
2016-01-14	DEFA14A	FORM 8-K	v428971_8k.htm

Stock Name	Country	Market Cap	PE Ratio
MAIA Biotechnology, Inc. (MAIA)	United States	$0.077B	-2.30
Valion Bio, Inc. (VBIO)	United States	$0.077B
Adicet Bio, Inc. (ACET)	United States	$0.078B	-0.81
Verrica Pharmaceuticals Inc. (VRCA)	United States	$0.076B	-3.39
Lifevantage Corp (LFVN)	United States	$0.078B	15.40
OS Therapies Inc (OSTX)	United States	$0.076B	-2.17
Gain Therapeutics, Inc. (GANX)	United States	$0.080B	-4.40
Aldeyra Therapeutics, Inc. (ALDX)	United States	$0.074B	-5.57
Cingulate Inc. (CING)	United States	$0.073B	-2.64
Spero Therapeutics, Inc. (SPRO)	United States	$0.073B	17.41